Ad Header



The Pulse of the Pharmaceutical Industry

Japanese drugmaker Daiichi wins damages from former Ranbaxy owners

Written by: | | Dated: Thursday, May 5th, 2016


RHC Holding, a company owned by one-time Ranbaxy controlling shareholder and billionaire Malvinder Singh, also said in a statement that the former owners were considering challenging the verdict.

Daiichi, which bought control of Ranbaxy in 2008 from a shareholder group led by brothers Malvinder and Shivinder, said in 2013 it believed former shareholders of the company had hidden information about U.S. regulatory probes into Ranbaxy. (

Daiichi, which agreed to sell Ranbaxy on to India’s Sun Pharmaceutical in 2014, could not be reached for comment during a public holiday in Japan.

RHC did not name the court that ordered them to pay the damage but Indian daily Economic Times and another source aware of the matter both said it was the Singapore International Arbitration Centre.

Pranav Mago, head of South Asia for Singapore International Arbitration Centre, declined to comment citing confidentiality agreements.


(Reporting by Devidutta Tripathy and Krishna N. Das; editing by David Clarke)

Source: Reuters Health

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

April 2018 Focus: Agency Profiles, Manny Awards and Annual Review


Ad Right Bottom

Main Navigation